Parkwoods Wealth Partners, LLC Tenaya Therapeutics, Inc. Transaction History
Parkwoods Wealth Partners, LLC
- $340 Billion
- Q4 2025
A detailed history of Parkwoods Wealth Partners, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Parkwoods Wealth Partners, LLC holds 17,000 shares of TNYA stock, worth $23,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,000
Previous 15,000
13.33%
Holding current value
$23,120
Previous $24.3 Million
50.22%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
98Shares Held
42MCall Options Held
313KPut Options Held
61.1K-
Column Group LLC San Francisco, CA9.4MShares$12.8 Million18.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.56MShares$11.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.5MShares$6.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.68MShares$2.28 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $56.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...